Orchestra BioMed Holdings OBIO SEC Filings

NASDAQ OBIO
$4.93 +0.19 (+3.90%)
As of: Sep 4, 2026 · 2:24 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Orchestra BioMed Holdings, Inc. (OBIO) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index